5Rober A,Kitera J,Broteory EG,et al.Clinical correlation between hypercoagulability and thromboetic phenomenon.Thromb Res,1994,74:125-131.
6Levin EG,Naragaj GR,Takiee T,et al.Latent tissue plasminogen activator produced by human endothelial cells in culture:Evidence for an enzymeinhibitor complex.Proc Natl Acad Sci USA,1996,93:6804-6809.
7Kruithof EKO,Gubrabi TD,Hunter I, et al.Demonstration of a fastacting inhibitor of plasminogen activators in human plasma.Blood,1994,84:1907-1911.
8Wimah B,Mecham RP,Mayer V. The role of the fibrinolytic system in deep vein thrombosis.J Lab Clin Med,1995,135:365-372.
9Nilsson IM,Nisch R,Fox JW,et al.Two different mechanisms in patients with venous thrombosis and defective fibrinolysis:Low concentration of plasminogen activator of increased concentration of plasminogen activator inhibitor.Br Med J,1995,310:2053-2065.
10Tomura S,Nakamura Y,Deguchi F,et al.Coagulation and fibrinolysis in patients with chronic renal failure and undergoing conservative treatment.Thromb Res,1991,64:81-89.
9Hou Weiping,Li Suzhi,Deng Yongming,et al.Plateau and plain of blood coagulation function in patients with primary nephrotic syndrome index analysis[J].Joumal of third military medical university,2009;23(8):566-567.
10C M Kirchmaier,D Pillitteri.Congenital thrombocytopathies[J].Der Interni st,2010;51(9): 1109-1114,1116-1117.
